Stefan Sillau
Concepts (427)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Parkinson Disease | 22 | 2024 | 462 | 2.300 |
Why?
| Multiple Sclerosis | 8 | 2024 | 438 | 0.970 |
Why?
| Palliative Care | 12 | 2024 | 706 | 0.880 |
Why?
| Seizures | 10 | 2024 | 402 | 0.860 |
Why?
| Epilepsies, Partial | 4 | 2025 | 43 | 0.840 |
Why?
| Drug Resistant Epilepsy | 4 | 2025 | 81 | 0.720 |
Why?
| Epilepsy | 5 | 2024 | 322 | 0.690 |
Why?
| Caregivers | 9 | 2024 | 809 | 0.680 |
Why?
| Quality of Life | 15 | 2024 | 2695 | 0.610 |
Why?
| Alzheimer Disease | 5 | 2024 | 516 | 0.570 |
Why?
| Natalizumab | 4 | 2021 | 40 | 0.510 |
Why?
| Parkinsonian Disorders | 3 | 2020 | 34 | 0.480 |
Why?
| Fingolimod Hydrochloride | 3 | 2020 | 39 | 0.460 |
Why?
| Humans | 103 | 2025 | 129847 | 0.450 |
Why?
| Immunologic Factors | 3 | 2020 | 229 | 0.400 |
Why?
| Middle Aged | 45 | 2025 | 31177 | 0.400 |
Why?
| Cognition | 7 | 2025 | 1125 | 0.400 |
Why?
| Aged | 37 | 2024 | 22107 | 0.390 |
Why?
| Cognition Disorders | 3 | 2024 | 505 | 0.380 |
Why?
| Atherosclerosis | 4 | 2019 | 402 | 0.370 |
Why?
| Cannabidiol | 2 | 2024 | 108 | 0.370 |
Why?
| Male | 61 | 2025 | 63759 | 0.370 |
Why?
| Retrospective Studies | 31 | 2024 | 14553 | 0.370 |
Why?
| Ambulatory Care | 3 | 2020 | 509 | 0.370 |
Why?
| Diabetic Neuropathies | 2 | 2023 | 96 | 0.360 |
Why?
| Charcot-Marie-Tooth Disease | 2 | 2022 | 21 | 0.360 |
Why?
| Female | 61 | 2025 | 68829 | 0.350 |
Why?
| Chagas Disease | 2 | 2021 | 38 | 0.340 |
Why?
| Sinusitis | 3 | 2021 | 211 | 0.340 |
Why?
| Music Therapy | 2 | 2021 | 22 | 0.340 |
Why?
| Adult | 38 | 2025 | 35634 | 0.330 |
Why?
| Stroke, Lacunar | 2 | 2019 | 4 | 0.310 |
Why?
| Neuropsychological Tests | 3 | 2025 | 1016 | 0.310 |
Why?
| Torticollis | 2 | 2019 | 12 | 0.310 |
Why?
| Rituximab | 2 | 2020 | 164 | 0.300 |
Why?
| Meningitis, Cryptococcal | 2 | 2019 | 30 | 0.300 |
Why?
| Cognitive Dysfunction | 2 | 2024 | 347 | 0.300 |
Why?
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2020 | 73 | 0.300 |
Why?
| Dystonic Disorders | 2 | 2019 | 24 | 0.300 |
Why?
| Young Adult | 21 | 2025 | 12467 | 0.280 |
Why?
| Cardiomyopathies | 2 | 2021 | 340 | 0.270 |
Why?
| Spirituality | 4 | 2021 | 79 | 0.270 |
Why?
| Medical Staff, Hospital | 2 | 2021 | 81 | 0.270 |
Why?
| Myelitis | 2 | 2018 | 98 | 0.260 |
Why?
| Cannabis | 2 | 2024 | 462 | 0.260 |
Why?
| Aged, 80 and over | 15 | 2024 | 7066 | 0.250 |
Why?
| Sepsis | 2 | 2022 | 576 | 0.250 |
Why?
| Neurosurgical Procedures | 2 | 2017 | 168 | 0.240 |
Why?
| Prevalence | 9 | 2024 | 2564 | 0.240 |
Why?
| Candidemia | 1 | 2024 | 10 | 0.230 |
Why?
| Stiff-Person Syndrome | 1 | 2024 | 11 | 0.230 |
Why?
| Anticonvulsants | 2 | 2025 | 209 | 0.230 |
Why?
| Candida | 1 | 2024 | 37 | 0.230 |
Why?
| Dronabinol | 2 | 2024 | 203 | 0.230 |
Why?
| Adaptation, Psychological | 5 | 2020 | 618 | 0.230 |
Why?
| Colorado | 13 | 2024 | 4410 | 0.230 |
Why?
| Magnetic Resonance Imaging | 10 | 2024 | 3397 | 0.220 |
Why?
| Child Abuse | 2 | 2022 | 513 | 0.220 |
Why?
| Nasal Polyps | 2 | 2016 | 59 | 0.220 |
Why?
| Telemedicine | 2 | 2024 | 792 | 0.220 |
Why?
| Aquaporin 4 | 1 | 2024 | 95 | 0.220 |
Why?
| Cerebral Amyloid Angiopathy | 1 | 2024 | 9 | 0.220 |
Why?
| Cost of Illness | 3 | 2021 | 277 | 0.220 |
Why?
| Dimethyl Fumarate | 2 | 2020 | 11 | 0.210 |
Why?
| Patient Care Team | 3 | 2019 | 603 | 0.210 |
Why?
| Inpatients | 3 | 2021 | 477 | 0.210 |
Why?
| Neuromyelitis Optica | 1 | 2024 | 129 | 0.200 |
Why?
| Severity of Illness Index | 8 | 2020 | 2739 | 0.200 |
Why?
| Migraine Disorders | 1 | 2024 | 101 | 0.200 |
Why?
| Apolipoprotein E4 | 1 | 2022 | 35 | 0.190 |
Why?
| Frontotemporal Dementia | 1 | 2022 | 37 | 0.190 |
Why?
| Conversion Disorder | 1 | 2022 | 9 | 0.190 |
Why?
| Vagus Nerve Stimulation | 1 | 2022 | 30 | 0.190 |
Why?
| Sleep | 3 | 2021 | 689 | 0.190 |
Why?
| Memory Consolidation | 1 | 2021 | 11 | 0.190 |
Why?
| Treatment Outcome | 13 | 2024 | 10241 | 0.190 |
Why?
| Adolescent | 17 | 2025 | 20451 | 0.180 |
Why?
| Chagas Cardiomyopathy | 1 | 2021 | 22 | 0.180 |
Why?
| Motor Disorders | 1 | 2021 | 15 | 0.180 |
Why?
| Risk Assessment | 6 | 2023 | 3269 | 0.180 |
Why?
| Dermatitis, Seborrheic | 1 | 2020 | 4 | 0.180 |
Why?
| Cohort Studies | 9 | 2024 | 5444 | 0.180 |
Why?
| Cross-Sectional Studies | 10 | 2021 | 5085 | 0.180 |
Why?
| Hospice and Palliative Care Nursing | 1 | 2022 | 72 | 0.170 |
Why?
| Intellectual Disability | 1 | 2022 | 148 | 0.170 |
Why?
| Incidence | 6 | 2024 | 2646 | 0.170 |
Why?
| Basal Ganglia Diseases | 1 | 2020 | 8 | 0.170 |
Why?
| Disease Progression | 4 | 2022 | 2628 | 0.170 |
Why?
| Vitamin D | 2 | 2015 | 380 | 0.170 |
Why?
| Terminal Care | 1 | 2023 | 216 | 0.170 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2022 | 1205 | 0.170 |
Why?
| Attitude of Health Personnel | 2 | 2021 | 1106 | 0.170 |
Why?
| Multiple Sclerosis, Chronic Progressive | 1 | 2020 | 26 | 0.170 |
Why?
| Sphenoid Bone | 2 | 2016 | 15 | 0.170 |
Why?
| Interferon-gamma | 1 | 2023 | 773 | 0.160 |
Why?
| Self Report | 3 | 2022 | 800 | 0.160 |
Why?
| Cytokines | 3 | 2022 | 2022 | 0.160 |
Why?
| Neurovascular Coupling | 1 | 2019 | 8 | 0.160 |
Why?
| Electronic Health Records | 2 | 2021 | 979 | 0.160 |
Why?
| Disabled Persons | 1 | 2021 | 138 | 0.160 |
Why?
| Risk Factors | 11 | 2024 | 9801 | 0.160 |
Why?
| Radiotherapy, Adjuvant | 2 | 2016 | 208 | 0.160 |
Why?
| Behavioral Symptoms | 1 | 2019 | 42 | 0.160 |
Why?
| Shock, Septic | 1 | 2021 | 209 | 0.160 |
Why?
| Glatiramer Acetate | 1 | 2019 | 18 | 0.160 |
Why?
| Critical Care Outcomes | 1 | 2018 | 12 | 0.150 |
Why?
| Streptococcal Infections | 1 | 2021 | 148 | 0.150 |
Why?
| Psychotherapy, Group | 1 | 2019 | 65 | 0.150 |
Why?
| Diabetes Mellitus, Type 2 | 3 | 2023 | 2444 | 0.150 |
Why?
| Diet, Ketogenic | 1 | 2018 | 37 | 0.150 |
Why?
| Cannabinoids | 1 | 2020 | 154 | 0.150 |
Why?
| Blepharospasm | 1 | 2018 | 7 | 0.150 |
Why?
| Restless Legs Syndrome | 1 | 2018 | 21 | 0.150 |
Why?
| Proxy | 1 | 2018 | 27 | 0.150 |
Why?
| Electroencephalography | 4 | 2022 | 409 | 0.150 |
Why?
| Fluoxetine | 1 | 2018 | 52 | 0.150 |
Why?
| Psychometrics | 2 | 2019 | 701 | 0.150 |
Why?
| Aftercare | 1 | 2020 | 206 | 0.140 |
Why?
| Basal Ganglia | 1 | 2018 | 53 | 0.140 |
Why?
| Clinical Laboratory Techniques | 1 | 2018 | 94 | 0.140 |
Why?
| Brain | 5 | 2022 | 2677 | 0.140 |
Why?
| Down Syndrome | 2 | 2022 | 478 | 0.140 |
Why?
| Neurology | 1 | 2019 | 103 | 0.140 |
Why?
| Central Nervous System Viral Diseases | 1 | 2018 | 73 | 0.140 |
Why?
| Subthalamic Nucleus | 1 | 2018 | 67 | 0.140 |
Why?
| Nutrition Surveys | 1 | 2019 | 260 | 0.140 |
Why?
| Transcranial Magnetic Stimulation | 1 | 2017 | 57 | 0.140 |
Why?
| Ambulatory Care Facilities | 1 | 2019 | 228 | 0.140 |
Why?
| Hypoxia-Ischemia, Brain | 1 | 2017 | 33 | 0.140 |
Why?
| Child | 14 | 2024 | 20962 | 0.140 |
Why?
| Neuromuscular Diseases | 1 | 2018 | 105 | 0.140 |
Why?
| Cranial Nerve Diseases | 1 | 2017 | 42 | 0.140 |
Why?
| Immunosuppressive Agents | 2 | 2019 | 858 | 0.130 |
Why?
| Autism Spectrum Disorder | 1 | 2022 | 386 | 0.130 |
Why?
| Follow-Up Studies | 7 | 2020 | 4896 | 0.130 |
Why?
| Movement Disorders | 1 | 2017 | 52 | 0.130 |
Why?
| Immunoglobulin G | 1 | 2021 | 851 | 0.130 |
Why?
| Interprofessional Relations | 1 | 2019 | 279 | 0.130 |
Why?
| Medical Marijuana | 1 | 2018 | 111 | 0.130 |
Why?
| Orbital Diseases | 1 | 2016 | 28 | 0.130 |
Why?
| Muscular Diseases | 1 | 2017 | 109 | 0.130 |
Why?
| Giant Cell Tumor of Bone | 1 | 2016 | 6 | 0.130 |
Why?
| Atrophy | 3 | 2024 | 170 | 0.130 |
Why?
| Deep Brain Stimulation | 1 | 2018 | 125 | 0.130 |
Why?
| Cerebellum | 1 | 2018 | 218 | 0.130 |
Why?
| Models, Theoretical | 1 | 2020 | 549 | 0.130 |
Why?
| Skull Base Neoplasms | 1 | 2016 | 25 | 0.130 |
Why?
| Dementia | 1 | 2019 | 227 | 0.130 |
Why?
| Craniocerebral Trauma | 1 | 2017 | 151 | 0.130 |
Why?
| Meningioma | 1 | 2016 | 82 | 0.120 |
Why?
| Radiotherapy, Intensity-Modulated | 1 | 2016 | 129 | 0.120 |
Why?
| Family | 2 | 2024 | 646 | 0.120 |
Why?
| Meningeal Neoplasms | 1 | 2016 | 94 | 0.120 |
Why?
| Regression Analysis | 2 | 2018 | 998 | 0.120 |
Why?
| Marijuana Smoking | 1 | 2018 | 247 | 0.120 |
Why?
| T-Lymphocytes | 1 | 2023 | 1937 | 0.120 |
Why?
| Longitudinal Studies | 3 | 2022 | 2724 | 0.120 |
Why?
| Motor Activity | 1 | 2019 | 684 | 0.120 |
Why?
| Stroke | 2 | 2020 | 1072 | 0.120 |
Why?
| United States | 9 | 2024 | 13913 | 0.110 |
Why?
| Burnout, Professional | 1 | 2021 | 411 | 0.110 |
Why?
| Craniofacial Abnormalities | 1 | 2015 | 65 | 0.110 |
Why?
| Data Collection | 2 | 2022 | 653 | 0.110 |
Why?
| Education, Medical, Graduate | 1 | 2019 | 443 | 0.110 |
Why?
| Hemodynamics | 1 | 2019 | 1094 | 0.110 |
Why?
| Patient Readmission | 1 | 2020 | 668 | 0.110 |
Why?
| Rhinitis | 1 | 2016 | 152 | 0.110 |
Why?
| Neonatal Screening | 1 | 2016 | 163 | 0.110 |
Why?
| Physicians | 1 | 2023 | 875 | 0.110 |
Why?
| Retinopathy of Prematurity | 1 | 2016 | 140 | 0.110 |
Why?
| Ureteroscopy | 1 | 2014 | 16 | 0.110 |
Why?
| Internet | 2 | 2024 | 620 | 0.110 |
Why?
| Urolithiasis | 1 | 2014 | 9 | 0.110 |
Why?
| Vitamin D Deficiency | 2 | 2015 | 177 | 0.110 |
Why?
| Proportional Hazards Models | 3 | 2024 | 1199 | 0.110 |
Why?
| Aspirin | 2 | 2016 | 380 | 0.110 |
Why?
| Behavioral Medicine | 1 | 2014 | 36 | 0.110 |
Why?
| Depressive Disorder | 1 | 2017 | 367 | 0.110 |
Why?
| Anxiety Disorders | 1 | 2017 | 357 | 0.110 |
Why?
| Nervous System Diseases | 1 | 2016 | 252 | 0.110 |
Why?
| Extremities | 1 | 2014 | 127 | 0.110 |
Why?
| Patient-Centered Care | 1 | 2019 | 508 | 0.110 |
Why?
| Neoplasm Recurrence, Local | 2 | 2016 | 957 | 0.110 |
Why?
| Chronic Disease | 2 | 2016 | 1724 | 0.110 |
Why?
| Tonsillectomy | 1 | 2015 | 82 | 0.110 |
Why?
| Eosinophilia | 1 | 2016 | 204 | 0.110 |
Why?
| Double-Blind Method | 3 | 2024 | 1877 | 0.100 |
Why?
| Airway Obstruction | 1 | 2015 | 154 | 0.100 |
Why?
| Rural Health Services | 1 | 2014 | 112 | 0.100 |
Why?
| Pulmonary Ventilation | 1 | 2013 | 78 | 0.100 |
Why?
| Mental Disorders | 1 | 2021 | 1035 | 0.100 |
Why?
| Primary Prevention | 1 | 2015 | 190 | 0.100 |
Why?
| Demography | 1 | 2014 | 279 | 0.100 |
Why?
| Prognosis | 4 | 2023 | 3773 | 0.100 |
Why?
| Refugees | 1 | 2014 | 68 | 0.100 |
Why?
| Tomography, X-Ray Computed | 4 | 2016 | 2511 | 0.100 |
Why?
| Antiviral Agents | 1 | 2018 | 719 | 0.100 |
Why?
| Coronary Vessels | 1 | 2014 | 239 | 0.100 |
Why?
| Birth Weight | 1 | 2016 | 505 | 0.100 |
Why?
| Movement | 1 | 2014 | 270 | 0.100 |
Why?
| Calcinosis | 1 | 2014 | 233 | 0.100 |
Why?
| Curriculum | 1 | 2019 | 928 | 0.100 |
Why?
| Weight Gain | 1 | 2016 | 510 | 0.100 |
Why?
| Teaching Rounds | 1 | 2013 | 69 | 0.100 |
Why?
| Coronary Disease | 1 | 2014 | 385 | 0.090 |
Why?
| Delivery of Health Care, Integrated | 1 | 2014 | 250 | 0.090 |
Why?
| Depression | 1 | 2020 | 1323 | 0.090 |
Why?
| Tissue Donors | 1 | 2014 | 391 | 0.090 |
Why?
| Environmental Monitoring | 1 | 2013 | 309 | 0.090 |
Why?
| Reproducibility of Results | 4 | 2022 | 3089 | 0.090 |
Why?
| Internal Medicine | 1 | 2013 | 247 | 0.090 |
Why?
| Sleep Apnea, Obstructive | 1 | 2015 | 279 | 0.090 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 430 | 0.090 |
Why?
| Interpersonal Relations | 1 | 2014 | 395 | 0.090 |
Why?
| Amyloid beta-Peptides | 2 | 2023 | 211 | 0.080 |
Why?
| Tissue and Organ Procurement | 1 | 2014 | 290 | 0.080 |
Why?
| Patient Outcome Assessment | 2 | 2023 | 127 | 0.080 |
Why?
| Surveys and Questionnaires | 6 | 2019 | 5437 | 0.080 |
Why?
| Cross Infection | 1 | 2012 | 219 | 0.080 |
Why?
| Time Factors | 5 | 2020 | 6550 | 0.080 |
Why?
| Obesity | 2 | 2021 | 2885 | 0.080 |
Why?
| Polysomnography | 3 | 2015 | 178 | 0.080 |
Why?
| Models, Statistical | 1 | 2013 | 624 | 0.080 |
Why?
| Case-Control Studies | 3 | 2023 | 3384 | 0.080 |
Why?
| Internship and Residency | 1 | 2019 | 1058 | 0.080 |
Why?
| Postoperative Complications | 2 | 2017 | 2481 | 0.080 |
Why?
| Health Status | 1 | 2014 | 758 | 0.080 |
Why?
| Phenotype | 1 | 2017 | 3062 | 0.080 |
Why?
| Quality of Health Care | 1 | 2013 | 610 | 0.070 |
Why?
| Brain Neoplasms | 1 | 2017 | 1149 | 0.070 |
Why?
| Coronary Artery Disease | 1 | 2015 | 680 | 0.070 |
Why?
| Calcium | 1 | 2014 | 1212 | 0.070 |
Why?
| Cardiac Surgical Procedures | 1 | 2013 | 509 | 0.070 |
Why?
| Prospective Studies | 5 | 2023 | 7158 | 0.070 |
Why?
| Blood Pressure | 1 | 2014 | 1736 | 0.070 |
Why?
| Muscle, Skeletal | 1 | 2017 | 1644 | 0.070 |
Why?
| Intensive Care Units | 1 | 2012 | 738 | 0.070 |
Why?
| Patient Participation | 2 | 2022 | 414 | 0.070 |
Why?
| Lung Diseases | 1 | 2013 | 743 | 0.070 |
Why?
| Health Services Accessibility | 1 | 2014 | 903 | 0.070 |
Why?
| Length of Stay | 1 | 2012 | 1133 | 0.070 |
Why?
| Recurrence | 2 | 2020 | 1013 | 0.060 |
Why?
| Asthma | 3 | 2016 | 2225 | 0.060 |
Why?
| Critical Illness | 1 | 2012 | 759 | 0.060 |
Why?
| Heart Defects, Congenital | 1 | 2013 | 796 | 0.060 |
Why?
| Survival Analysis | 2 | 2019 | 1271 | 0.060 |
Why?
| Feasibility Studies | 2 | 2019 | 870 | 0.060 |
Why?
| Influenza, Human | 1 | 2011 | 602 | 0.060 |
Why?
| Hypertension | 1 | 2014 | 1242 | 0.060 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 1284 | 0.060 |
Why?
| Candida tropicalis | 1 | 2024 | 4 | 0.060 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2021 | 1368 | 0.060 |
Why?
| Sleep Wake Disorders | 2 | 2019 | 255 | 0.060 |
Why?
| Child, Preschool | 4 | 2020 | 10522 | 0.050 |
Why?
| Research Design | 2 | 2021 | 1045 | 0.050 |
Why?
| Comorbidity | 2 | 2021 | 1551 | 0.050 |
Why?
| Neurologists | 1 | 2024 | 20 | 0.050 |
Why?
| Amyloidogenic Proteins | 1 | 2023 | 16 | 0.050 |
Why?
| Pandemics | 2 | 2022 | 1500 | 0.050 |
Why?
| Syncope | 1 | 2024 | 51 | 0.050 |
Why?
| Intermediate Filaments | 1 | 2023 | 27 | 0.050 |
Why?
| Primary Health Care | 1 | 2014 | 1687 | 0.050 |
Why?
| Anxiety | 2 | 2021 | 976 | 0.050 |
Why?
| Tremor | 1 | 2024 | 60 | 0.050 |
Why?
| Death | 1 | 2024 | 117 | 0.050 |
Why?
| Sensitivity and Specificity | 2 | 2020 | 1847 | 0.050 |
Why?
| Neurofilament Proteins | 1 | 2023 | 43 | 0.050 |
Why?
| Vaccination | 1 | 2011 | 1348 | 0.050 |
Why?
| Cerebral Hemorrhage | 1 | 2024 | 105 | 0.050 |
Why?
| tau Proteins | 1 | 2023 | 77 | 0.050 |
Why?
| Myelin P0 Protein | 1 | 2022 | 7 | 0.050 |
Why?
| Imipramine | 1 | 2022 | 12 | 0.050 |
Why?
| Kaplan-Meier Estimate | 1 | 2024 | 851 | 0.050 |
Why?
| Biomarkers | 2 | 2023 | 3971 | 0.050 |
Why?
| Hypertension, Pulmonary | 1 | 2013 | 1897 | 0.050 |
Why?
| Infusions, Intravenous | 1 | 2023 | 402 | 0.050 |
Why?
| Facial Expression | 1 | 2022 | 72 | 0.050 |
Why?
| Pain | 2 | 2018 | 791 | 0.050 |
Why?
| Healthy Volunteers | 1 | 2022 | 201 | 0.050 |
Why?
| Polymerization | 1 | 2022 | 124 | 0.050 |
Why?
| Vagus Nerve | 1 | 2022 | 86 | 0.050 |
Why?
| Reference Standards | 1 | 2022 | 176 | 0.050 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 147 | 0.050 |
Why?
| Streptococcus anginosus | 1 | 2021 | 9 | 0.050 |
Why?
| Catalysis | 1 | 2022 | 312 | 0.050 |
Why?
| Inflammation | 2 | 2022 | 2748 | 0.040 |
Why?
| Predictive Value of Tests | 2 | 2019 | 1951 | 0.040 |
Why?
| Oncology Service, Hospital | 1 | 2021 | 16 | 0.040 |
Why?
| Interneurons | 1 | 2022 | 120 | 0.040 |
Why?
| Immune System | 1 | 2022 | 175 | 0.040 |
Why?
| Meta-Analysis as Topic | 1 | 2021 | 170 | 0.040 |
Why?
| Hospitals, University | 1 | 2021 | 180 | 0.040 |
Why?
| Lung | 1 | 2013 | 3940 | 0.040 |
Why?
| Outpatients | 1 | 2024 | 375 | 0.040 |
Why?
| Longevity | 1 | 2021 | 155 | 0.040 |
Why?
| Serine | 1 | 2021 | 137 | 0.040 |
Why?
| Reaction Time | 1 | 2022 | 411 | 0.040 |
Why?
| Astrocytes | 1 | 2022 | 197 | 0.040 |
Why?
| Efficiency, Organizational | 1 | 2021 | 134 | 0.040 |
Why?
| Medical Informatics | 1 | 2021 | 99 | 0.040 |
Why?
| Monitoring, Physiologic | 1 | 2022 | 266 | 0.040 |
Why?
| Electrodes, Implanted | 1 | 2020 | 105 | 0.040 |
Why?
| Age Distribution | 1 | 2020 | 372 | 0.040 |
Why?
| Multiple System Atrophy | 1 | 2019 | 6 | 0.040 |
Why?
| Sex Distribution | 1 | 2020 | 359 | 0.040 |
Why?
| Supranuclear Palsy, Progressive | 1 | 2019 | 11 | 0.040 |
Why?
| Peptide Fragments | 1 | 2023 | 695 | 0.040 |
Why?
| Antibodies, Viral | 1 | 2023 | 602 | 0.040 |
Why?
| Infant | 3 | 2018 | 9018 | 0.040 |
Why?
| Developmental Disabilities | 1 | 2022 | 254 | 0.040 |
Why?
| Income | 1 | 2020 | 188 | 0.040 |
Why?
| Maintenance Chemotherapy | 1 | 2019 | 22 | 0.040 |
Why?
| Music | 1 | 2019 | 39 | 0.040 |
Why?
| Lewy Body Disease | 1 | 2019 | 29 | 0.040 |
Why?
| Pragmatic Clinical Trials as Topic | 1 | 2019 | 62 | 0.040 |
Why?
| Logistic Models | 2 | 2014 | 1989 | 0.040 |
Why?
| Induction Chemotherapy | 1 | 2019 | 70 | 0.040 |
Why?
| Symptom Assessment | 1 | 2019 | 125 | 0.040 |
Why?
| Gait | 1 | 2021 | 280 | 0.040 |
Why?
| Stroke Volume | 1 | 2021 | 593 | 0.040 |
Why?
| Administration, Oral | 1 | 2020 | 787 | 0.040 |
Why?
| Carnitine | 1 | 2018 | 76 | 0.040 |
Why?
| Demyelinating Diseases | 1 | 2019 | 84 | 0.040 |
Why?
| Phosphorus | 1 | 2018 | 92 | 0.040 |
Why?
| Muscle Spasticity | 1 | 2018 | 55 | 0.040 |
Why?
| Health Services | 1 | 2019 | 99 | 0.040 |
Why?
| Ventricular Function, Left | 1 | 2021 | 529 | 0.040 |
Why?
| B-Lymphocytes | 1 | 2023 | 816 | 0.040 |
Why?
| Age of Onset | 1 | 2019 | 494 | 0.040 |
Why?
| Comparative Effectiveness Research | 1 | 2019 | 151 | 0.040 |
Why?
| Diffusion Tensor Imaging | 1 | 2018 | 76 | 0.040 |
Why?
| Gadolinium | 1 | 2018 | 78 | 0.040 |
Why?
| Neural Pathways | 1 | 2019 | 301 | 0.040 |
Why?
| Arrhythmias, Cardiac | 1 | 2020 | 322 | 0.040 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2023 | 756 | 0.040 |
Why?
| Tandem Mass Spectrometry | 1 | 2021 | 528 | 0.040 |
Why?
| Neural Conduction | 1 | 2017 | 83 | 0.030 |
Why?
| Emotions | 1 | 2022 | 545 | 0.030 |
Why?
| Disability Evaluation | 1 | 2019 | 285 | 0.030 |
Why?
| ROC Curve | 1 | 2018 | 504 | 0.030 |
Why?
| Qualitative Research | 1 | 2024 | 1235 | 0.030 |
Why?
| Exophthalmos | 1 | 2016 | 18 | 0.030 |
Why?
| Hippocampus | 1 | 2022 | 844 | 0.030 |
Why?
| Sex Characteristics | 1 | 2022 | 735 | 0.030 |
Why?
| Temporomandibular Joint | 1 | 2016 | 8 | 0.030 |
Why?
| Frontal Bone | 1 | 2016 | 12 | 0.030 |
Why?
| Cranial Fossa, Middle | 1 | 2016 | 7 | 0.030 |
Why?
| Occipital Bone | 1 | 2016 | 18 | 0.030 |
Why?
| Neuroimaging | 1 | 2019 | 279 | 0.030 |
Why?
| Brain Ischemia | 1 | 2020 | 321 | 0.030 |
Why?
| Intraoperative Complications | 1 | 2017 | 129 | 0.030 |
Why?
| Drug Administration Schedule | 1 | 2018 | 766 | 0.030 |
Why?
| Temporal Bone | 1 | 2016 | 49 | 0.030 |
Why?
| Sex Factors | 1 | 2022 | 1973 | 0.030 |
Why?
| Brain Mapping | 1 | 2019 | 575 | 0.030 |
Why?
| Interviews as Topic | 1 | 2019 | 709 | 0.030 |
Why?
| Neoplasm Grading | 1 | 2016 | 283 | 0.030 |
Why?
| Self Efficacy | 1 | 2019 | 377 | 0.030 |
Why?
| Neoplasm, Residual | 1 | 2016 | 121 | 0.030 |
Why?
| Sleep Stages | 1 | 2015 | 45 | 0.030 |
Why?
| Activities of Daily Living | 1 | 2018 | 384 | 0.030 |
Why?
| Contrast Media | 1 | 2018 | 394 | 0.030 |
Why?
| Electromyography | 1 | 2017 | 381 | 0.030 |
Why?
| Actigraphy | 1 | 2015 | 98 | 0.030 |
Why?
| Drug Hypersensitivity | 1 | 2016 | 81 | 0.030 |
Why?
| Psychiatric Status Rating Scales | 1 | 2017 | 534 | 0.030 |
Why?
| Thinness | 1 | 2015 | 89 | 0.030 |
Why?
| Sleep Apnea Syndromes | 1 | 2015 | 82 | 0.030 |
Why?
| Adenoidectomy | 1 | 2015 | 65 | 0.030 |
Why?
| Age Factors | 1 | 2022 | 3161 | 0.030 |
Why?
| Pilot Projects | 1 | 2019 | 1597 | 0.030 |
Why?
| San Francisco | 1 | 2014 | 51 | 0.030 |
Why?
| Infant, Newborn | 2 | 2016 | 5772 | 0.030 |
Why?
| Sampling Studies | 1 | 2014 | 96 | 0.030 |
Why?
| Combined Modality Therapy | 1 | 2016 | 1201 | 0.030 |
Why?
| False Positive Reactions | 1 | 2014 | 114 | 0.030 |
Why?
| Biopsy | 1 | 2017 | 1089 | 0.030 |
Why?
| Patient Reported Outcome Measures | 1 | 2017 | 374 | 0.030 |
Why?
| Sternotomy | 1 | 2013 | 25 | 0.030 |
Why?
| Physician-Nurse Relations | 1 | 2013 | 16 | 0.030 |
Why?
| Lithotripsy | 1 | 2014 | 43 | 0.030 |
Why?
| Leukotriene E4 | 1 | 2013 | 26 | 0.030 |
Why?
| Pulmonary Gas Exchange | 1 | 2013 | 121 | 0.030 |
Why?
| Odds Ratio | 1 | 2016 | 1022 | 0.030 |
Why?
| Thoracotomy | 1 | 2013 | 75 | 0.030 |
Why?
| Monte Carlo Method | 1 | 2013 | 143 | 0.030 |
Why?
| Linear Models | 1 | 2015 | 822 | 0.030 |
Why?
| Hospitals, Teaching | 1 | 2013 | 114 | 0.030 |
Why?
| Drug Resistance | 1 | 2013 | 165 | 0.030 |
Why?
| Paranasal Sinuses | 1 | 2013 | 76 | 0.030 |
Why?
| Olfaction Disorders | 1 | 2013 | 60 | 0.030 |
Why?
| Critical Care | 1 | 2017 | 552 | 0.030 |
Why?
| Spirometry | 1 | 2013 | 257 | 0.030 |
Why?
| Diabetic Angiopathies | 1 | 2015 | 261 | 0.020 |
Why?
| Patient Acceptance of Health Care | 1 | 2019 | 763 | 0.020 |
Why?
| Gestational Age | 1 | 2016 | 876 | 0.020 |
Why?
| Vital Capacity | 1 | 2013 | 290 | 0.020 |
Why?
| Coronary Angiography | 1 | 2014 | 306 | 0.020 |
Why?
| Disease-Free Survival | 1 | 2014 | 647 | 0.020 |
Why?
| Paper | 1 | 2011 | 10 | 0.020 |
Why?
| Forced Expiratory Volume | 1 | 2013 | 508 | 0.020 |
Why?
| Health Care Surveys | 1 | 2014 | 558 | 0.020 |
Why?
| Disease Models, Animal | 1 | 2022 | 4077 | 0.020 |
Why?
| Personnel, Hospital | 1 | 2011 | 25 | 0.020 |
Why?
| Mutation | 1 | 2022 | 3706 | 0.020 |
Why?
| Confidence Intervals | 1 | 2012 | 318 | 0.020 |
Why?
| Aging | 1 | 2021 | 1774 | 0.020 |
Why?
| Premature Birth | 1 | 2015 | 317 | 0.020 |
Why?
| Particulate Matter | 1 | 2013 | 247 | 0.020 |
Why?
| Urban Population | 1 | 2014 | 443 | 0.020 |
Why?
| Eosinophils | 1 | 2013 | 324 | 0.020 |
Why?
| Patient Admission | 1 | 2012 | 183 | 0.020 |
Why?
| Tobacco Smoke Pollution | 1 | 2013 | 231 | 0.020 |
Why?
| Oxygen Consumption | 1 | 2013 | 672 | 0.020 |
Why?
| Exercise Test | 1 | 2013 | 614 | 0.020 |
Why?
| Cause of Death | 1 | 2012 | 395 | 0.020 |
Why?
| Socioeconomic Factors | 1 | 2014 | 1214 | 0.020 |
Why?
| Recovery of Function | 1 | 2013 | 645 | 0.020 |
Why?
| Computer Simulation | 1 | 2013 | 941 | 0.020 |
Why?
| Models, Biological | 1 | 2016 | 1724 | 0.020 |
Why?
| Algorithms | 1 | 2016 | 1617 | 0.020 |
Why?
| Healthcare Disparities | 1 | 2014 | 580 | 0.020 |
Why?
| Practice Guidelines as Topic | 1 | 2015 | 1514 | 0.020 |
Why?
| Influenza Vaccines | 1 | 2011 | 533 | 0.020 |
Why?
| Patient Discharge | 1 | 2012 | 856 | 0.020 |
Why?
| Mice | 1 | 2022 | 16983 | 0.010 |
Why?
| Animals | 1 | 2022 | 35409 | 0.010 |
Why?
|
|
Sillau's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|